Association between primary graft dysfunction among lung, kidney and heart recipients from the same multiorgan donor. (1/98)

 (+info)

Impact of human donor lung gene expression profiles on survival after lung transplantation: a case-control study. (2/98)

 (+info)

Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome. (3/98)

 (+info)

Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation. (4/98)

 (+info)

Participation of autophagy in the initiation of graft dysfunction after rat liver transplantation. (5/98)

Better ways to prevent the cold ischemia-warm reperfusion (CI/WR) injury associated with liver transplantation are needed, and many investigations have focused on the molecular mechanisms of this injury. However, the mechanisms reported to date are controversial and no improvement in therapy has resulted. Here, using prolonged CI and orthotopic transplantation of rat liver grafts, we found that the CI/WR injury was closely associated with autophagy. By 15 minutes after the start of WR, small masses of hepatocytes that possessed abundant autophagosomes and autolysosomes frequently dissociated from the hepatic cords and obstructed the sinusoid, causing massive necrosis of hepatocytes within 2 hours. The cell masses included TUNEL-positive nuclei without caspase-3 and -7 activation. Autophagy suppression with the phosphatidylinositol 3-kinase (PI3K) inhibitors, wortmannin or LY294002, reduced both liver damage and the mortality rate of recipient rats. To elucidate the downstream mechanisms of this autophagic pathway, liver grafts were treated with aspartic and cysteine proteinase inhibitors, pepstatin and leupeptin. This treatment also significantly improved the survival rate of recipient rats. These data suggest that autophagy-associated hepatocyte death triggers liver graft dysfunction. The protective effects of suppressing autophagy may suggest new ways to prevent CI/WR injury of the liver.  (+info)

Does anaesthetic management affect early outcomes after lung transplant? An exploratory analysis. (6/98)

 (+info)

Concurrent Kaposi's sarcoma, tuberculosis, and allograft dysfunction in a renal transplant patient. (7/98)

The major long-term complications of renal transplantation (RT) include cardio-vascular disease, opportunistic infections, malignancies, and chronic allograft nephropathy. Long-term complications are generally considered as those occurring more than 1 year post trans-plantation; however, some of the complications can occur earlier. We present a 58-year-old man who presented with multiple complications of RT concurrently and relatively early post trans-plantation including Kaposi's sarcoma, tuberculosis and allograft dysfunction.  (+info)

Soluble p-selectin and the risk of primary graft dysfunction after lung transplantation. (8/98)

 (+info)